Moreover, CRs have also been observed in similar malignancies like SNUC [29] treated with various combinations of ICIs, including ipilimumab and COX2 inhibitors [30], and in NUT midline carcinoma treated with nivolumab and BET inhibitors [31]. This evidence concerns the gene DNER and nut midline carcinoma.